BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 26315930)

  • 1. Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia.
    Narita A; Muramatsu H; Sekiya Y; Okuno Y; Sakaguchi H; Nishio N; Yoshida N; Wang X; Xu Y; Kawashima N; Doisaki S; Hama A; Takahashi Y; Kudo K; Moritake H; Kobayashi M; Kobayashi R; Ito E; Yabe H; Ohga S; Ohara A; Kojima S;
    Haematologica; 2015 Dec; 100(12):1546-52. PubMed ID: 26315930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations.
    Marotta S; Pagliuca S; Risitano AM
    Expert Rev Hematol; 2014 Dec; 7(6):775-89. PubMed ID: 25331515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paroxysmal nocturnal haemoglobinuria phenotype cells and leucocyte subset telomere length in childhood acquired aplastic anaemia.
    Tutelman PR; Aubert G; Milner RA; Dalal BI; Schultz KR; Deyell RJ
    Br J Haematol; 2014 Mar; 164(5):717-21. PubMed ID: 24236830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine.
    Scheinberg P; Marte M; Nunez O; Young NS
    Haematologica; 2010 Jul; 95(7):1075-80. PubMed ID: 20595102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The dynamics of paroxysmal nocturnal hemoglobinuria clone in patients with aplastic anemia in process of immune suppressive therapy].
    Fidarova ZT; Mikhailova EA; Galtseva IV; Lugovskaya SA; Naumova EV; Troitskaya VV; Ustinova EN; Davydova YO; Kapranov NM; Abramova AV; Parovichnikova EN; Savchenko VG
    Klin Lab Diagn; 2016 Aug; 61(8):490-4. PubMed ID: 30601641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study.
    Kulagin A; Lisukov I; Ivanova M; Golubovskaya I; Kruchkova I; Bondarenko S; Vavilov V; Stancheva N; Babenko E; Sipol A; Pronkina N; Kozlov V; Afanasyev B
    Br J Haematol; 2014 Feb; 164(4):546-54. PubMed ID: 24261566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of paroxysmal nocturnal hemoglobinuria clones in response to immunosuppressive therapy of patients with severe aplastic anemia.
    Zhao X; Zhang L; Jing L; Zhou K; Li Y; Peng G; Ye L; Li Y; Li J; Fan H; Song L; Yang W; Zhang F
    Ann Hematol; 2015 Jul; 94(7):1105-10. PubMed ID: 25784221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers for predicting clinical response to immunosuppressive therapy in aplastic anemia.
    Narita A; Kojima S
    Int J Hematol; 2016 Aug; 104(2):153-8. PubMed ID: 27091471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of allogeneic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria with or without aplastic anemia.
    Lee SE; Park SS; Jeon YW; Yoon JH; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Lee JW
    Eur J Haematol; 2017 Oct; 99(4):336-343. PubMed ID: 28675769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anemia with aplastic anemia, paroxysmal nocturnal hemoglobinuria and myelodysplastic syndromes].
    Passweg JR
    Ther Umsch; 2010 May; 67(5):251-5. PubMed ID: 20509122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood lymphocyte telomere length as a predictor of response to immunosuppressive therapy in childhood aplastic anemia.
    Sakaguchi H; Nishio N; Hama A; Kawashima N; Wang X; Narita A; Doisaki S; Xu Y; Muramatsu H; Yoshida N; Takahashi Y; Kudo K; Moritake H; Nakamura K; Kobayashi R; Ito E; Yabe H; Ohga S; Ohara A; Kojima S;
    Haematologica; 2014 Aug; 99(8):1312-6. PubMed ID: 24816243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective eculizumab therapy followed by BMT in a boy with paroxysmal nocturnal hemoglobinuria.
    Oshiro H; Goi K; Akahane K; Inukai T; Sugita K
    Pediatr Int; 2015 Apr; 57(2):e27-9. PubMed ID: 25868955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins.
    Schrezenmeier H; Hertenstein B; Wagner B; Raghavachar A; Heimpel H
    Exp Hematol; 1995 Jan; 23(1):81-7. PubMed ID: 7995374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful reduced-intensity conditioning hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria with aplastic anemia in two children.
    Andolina JR; Reinish AL; Akhtar R; Noronha S; Shand JC; Girvin A; Korones DN; Bruckner LB; Mullen CA; Curran KJ; Boulad F
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27218. PubMed ID: 29722478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Outcomes of allogeneic hematopoietic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria compared to paroxysmal nocturnal hemoglobinuria-aplastic anemia syndrome].
    Liu LM; Zhou HF; Wang QY; Qiu HY; Tang XW; Han Y; Fu CC; Jin ZM; Chen SN; Sun AN; Miao M; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jun; 40(6):472-476. PubMed ID: 31340619
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiparameter FLAER-based flow cytometry for screening of paroxysmal nocturnal hemoglobinuria enhances detection rates in patients with aplastic anemia.
    Sachdeva MU; Varma N; Chandra D; Bose P; Malhotra P; Varma S
    Ann Hematol; 2015 May; 94(5):721-8. PubMed ID: 25465235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometry screening for paroxysmal nocturnal hemoglobinuria: A single-center experience in Saudi Arabia.
    AlGhasham N; Abulkhair Y; Khalil S
    Cytometry B Clin Cytom; 2015; 88(6):389-94. PubMed ID: 26296648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxysmal nocturnal hemoglobinuria clones in children with acquired aplastic anemia: a multicentre study.
    Timeus F; Crescenzio N; Longoni D; Doria A; Foglia L; Pagliano S; Vallero S; Decimi V; Svahn J; Palumbo G; Ruggiero A; Martire B; Pillon M; Marra N; Dufour C; Ramenghi U; Saracco P
    PLoS One; 2014; 9(7):e101948. PubMed ID: 25007335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paroxysmal nocturnal hemoglobinuria.
    Smith LJ
    Clin Lab Sci; 2004; 17(3):172-7. PubMed ID: 15314892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of paroxysmal nocturnal hemoglobinuria clone in immunosuppressive therapy for children with severe aplastic anemia.
    Li J; Zong SY; Yin ZX; Gao YY; Liu LP; Wan Y; Lan Y; Gong XW; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Mar; 24(3):303-308. PubMed ID: 35351262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.